Free Trial

Acumen Pharmaceuticals (ABOS) Earnings Date, Estimates & Call Transcripts

$2.87
-0.06 (-2.05%)
(As of 03:45 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 13Estimated
Actual EPS
(May. 20)
-$0.25 Missed By -$0.02
Consensus EPS
(May. 20)
-$0.23
Skip Charts & View Estimated and Actual Earnings Data

ABOS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ABOS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Acumen Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.26)($0.26)($0.26)
Q2 20241($0.25)($0.25)($0.25)
Q3 20241($0.25)($0.25)($0.25)
Q4 20241($0.25)($0.25)($0.25)
FY 20244($1.01)($1.01)($1.01)

ABOS Earnings Date and Information

Acumen Pharmaceuticals last posted its earnings results on May 20th, 2024. The reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.23) by $0.02. Acumen Pharmaceuticals has generated ($1.06) earnings per share over the last year (($1.06) diluted earnings per share). Earnings for Acumen Pharmaceuticals are expected to decrease in the coming year, from ($1.13) to ($1.37) per share. Acumen Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.

Acumen Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/13/2024
(Estimated)
------- 
5/20/2024Q1 2024($0.23)($0.25)($0.02)($0.25)--      
3/26/2024Q4 2023($0.29)($0.29)-($0.29)--
11/13/2023Q3 2023($0.31)($0.24)+$0.07($0.24)--    
8/8/2023Q2 2023($0.36)($0.28)+$0.08($0.28)--
5/9/2023Q1 2023($0.33)($0.28)+$0.05($0.28)--
3/27/2023Q4 2022($0.28)($0.32)($0.04)($0.32)--    
11/14/2022Q3 2022($0.27)($0.26)+$0.01($0.26)--
8/15/2022Q2 2022($0.24)($0.25)($0.01)($0.25)--
5/16/2022Q1 2022-($0.23)($0.23)($0.23)--
11/14/2021Q3($0.17)($0.10)+$0.07($0.10)--
8/15/2021Q2 2021($0.17)($7.91)($7.74)$126.11--    

Acumen Pharmaceuticals Earnings - Frequently Asked Questions

When is Acumen Pharmaceuticals's earnings date?

Acumen Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on ABOS's earnings history.

Did Acumen Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Acumen Pharmaceuticals (NASDAQ:ABOS) missed the analysts' consensus estimate of ($0.23) by $0.02 with a reported earnings per share (EPS) of ($0.25). Learn more on analysts' earnings estimate vs. ABOS's actual earnings.

How can I listen to Acumen Pharmaceuticals's earnings conference call?

The conference call for Acumen Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read Acumen Pharmaceuticals's conference call transcript?

The conference call transcript for Acumen Pharmaceuticals's latest earnings report can be read online. Read Transcript

How can I view Acumen Pharmaceuticals's earnings report?

Acumen Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing

How much profit does Acumen Pharmaceuticals generate each year?

Acumen Pharmaceuticals (NASDAQ:ABOS) has a recorded net income of -$52.37 million. ABOS has generated -$1.06 earnings per share over the last four quarters.

What is Acumen Pharmaceuticals's EPS forecast for next year?

Acumen Pharmaceuticals's earnings are expected to decrease from ($1.13) per share to ($1.37) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ABOS) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners